RBC Capital Maintains Outperform on Versigent, Lowers Price Target to $52
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Tom Narayan maintains Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $53 to $52.
RBC Capital analyst Tom Narayan maintains Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $53 to $52.